TipRanks
Go Ultimate55% OFF

Elixirr International Plc (ELIX) AI Stock Analysis

GB:ELIX

Elixirr International Plc

(LSE:ELIX)

Select Model
Rating:72Outperform
Price Target:GBX 559.00▲(12.70% Upside)
Action:reiterated
Date:09/28/26

The score is driven primarily by strong underlying business performance and a very appealing valuation (low P/E and high dividend yield), reinforced by a positive earnings call highlighting record results and growth initiatives. These are offset by a weak technical setup (downtrend and bearish MACD) and financial watch items around higher leverage and softer operating cash flow support.

Positive Factors
Strong revenue and profit growthStrong revenue and EBITDA growth indicates continued demand for Elixirr’s consulting and transformation services. The combination of top-line expansion and a 31% adjusted EBITDA margin provides resources to invest in capabilities, talent, and geographic reach over the next several quarters.
Negative Factors
Higher acquisition-driven leverageThe sharp increase in net debt reduces financial flexibility compared with Elixirr’s previously low-leverage profile. Higher borrowing also adds interest costs and makes future acquisition funding more dependent on cash generation, while management’s deleveraging target still needs to be delivered.

Elixirr International Plc (ELIX) vs. iShares MSCI United Kingdom ETF (EWC)

-50%-40%-30%-20%-10%0%10%20%30%GB:ELIX-38.42%EWC+21.27%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
GBP 249.18M
Dividend Yield
4.56%
Average Volume (3M)
120.57K
Price to Earnings (P/E)
11.5
Beta (1Y)
1.02
Revenue Growth
28.85%
EPS Growth
9.91%
Country
UK
Employees
730
Sector
Industrials
Sector Strength
63
Industry
Consulting Services

Elixirr International Plc Business Overview & Revenue Model

Company Description

Elixirr International plc, along with its various subsidiaries, delivers expert management consulting services across the United Kingdom, the United States, and other international territories. The company's core offerings encompass creative strategi...

How the Company Makes Money

Elixirr primarily makes money by delivering professional services to clients under consulting engagements. Revenue is generated from fees billed for advisory and delivery work (typically based on time-and-materials day rates or fixed-fee project scop...

Elixirr International Plc Earnings Call Summary

Earnings Call Date:Sep 20, 2026(Q2-2026)|% Change Since:-20.26%|Next Earnings Date:Apr 04, 2027
Earnings Call SentimentPositive

The call was strongly positive overall, with record H1 results, 25% revenue growth, 29% adjusted EBITDA growth, a 31% margin, 185% AI revenue growth, expanding client relationships, successful cross-selling, and continued capability and geographic expansion. The main challenges were the GBP 1.6 million FX headwind, completed programs affecting organic growth, low seasonal and acquisition-related cash flow, higher net debt, acquisition-related interest and share issuance, and an acknowledged valuation gap. Highlights significantly outweighed the lowlights.

Positive Updates

Record H1 Financial Performance
H1 2026 revenue increased 25% to GBP 89.0 million, gross profit increased 26%, adjusted EBITDA increased 29% to GBP 27.6 million, and the adjusted EBITDA margin was 31.0%, up one percentage point on the prior comparable period.

Negative Updates

Foreign Exchange Headwind
A 4% weakening of the U.S. dollar relative to the pound created a GBP 1.6 million FX headwind in the period.

Company Guidance

Management said the four pillar growth strategy remains the same: “We will continue to do organic growth,” “continue to deepen our client relationships,” “continue to do selective programmatic M&A,” and “look to sustain our premium margins”; the acquisition strategy “will be continuing,” and the company expects to “end the year with a significantly lower leverage position than the GBP 56.5 million” of net debt at H1 2026. The call also presented a scenario “where we have a 20% growth rate in revenue, EBITDA, and share price,” with the business becoming “broadly a GBP 1 billion market cap business by 2031,” with “18% dilution” and existing shareholders owning “roughly GBP 850 million” and “3x the value that it is today.”

Elixirr International Plc Financial Statement Overview

Summary

Strong multi-year revenue scaling and still-healthy profitability/returns, but tempered by margin compression, a sharp increase in leverage in 2025, and weaker operating cash flow support versus the prior year.

Income Statement

84Very Positive

Balance Sheet

76Positive

Cash Flow

72Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue167.15M149.60M111.34M85.89M71.75M50.61M
Gross Profit49.50M44.80M35.81M29.26M23.16M17.70M
EBITDA44.97M39.55M27.96M25.78M20.02M14.46M
Net Income21.02M19.70M16.38M17.24M12.87M10.14M
Balance Sheet
Total Assets272.98M251.08M175.89M154.40M128.66M107.17M
Cash, Cash Equivalents and Short-Term Investments2.52M5.05M7.53M18.13M20.43M31.80M
Total Debt63.55M33.52M4.90M5.36M5.14M5.25M
Total Liabilities120.23M108.56M43.78M34.84M32.74M21.13M
Stockholders Equity152.75M142.53M132.11M119.56M95.92M86.04M
Cash Flow
Free Cash Flow25.52M31.48M28.76M16.67M15.40M14.23M
Operating Cash Flow25.57M31.55M28.84M16.79M15.73M14.33M
Investing Cash Flow-55.17M-36.56M-21.11M-14.82M-18.53M-3.24M
Financing Cash Flow29.47M2.92M-18.58M-4.06M-8.85M3.11M

Elixirr International Plc Technical Analysis

Technical Analysis SentimentNegative
Last Price496.00

Price Trends

50DMA546.30Negative
100DMA602.47Negative
200DMA646.69Negative

Market Momentum

MACD-12.03Negative
RSI42.12Neutral
STOCH64.21Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ELIX, the sentiment is Negative. The current price of 496.00 is below the 20-day moving average (MA) of 505.05, below the 50-day MA of 546.30, and below the 200-day MA of 646.69, indicating a bearish trend. The MACD of -12.03 indicates Negative momentum. The RSI at 42.12 is Neutral, neither overbought nor oversold. The STOCH value of 64.21 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:ELIX.

Elixirr International Plc Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

GB:ELIX against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
GB:ELIXGB:ELIX72OutperformGBP 249.65M11.5314.24%4.56%28.85%9.91%
GB:YOUGB:YOU70OutperformGBP 318.17M55.893.05%3.40%1.98%-57.39%
GB:DATAGB:DATA65NeutralGBP 421.66M13.3012.09%2.33%8.63%139.90%
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
GB:SRPGB:SRP62NeutralGBP 2.75B18.7517.55%1.61%1.20%221.80%
GB:GTLYGB:GTLY61NeutralGBP 98.18M31.784.61%7.41%8.23%118.63%
GB:CPIGB:CPI47NeutralGBP 307.23M-1.53-677.10%―-16.13%-1315.87%

* Industrials Sector Average

Performance Comparison

-40%-20%0%20%GB:ELIXGB:CPIGB:GTLYGB:DATAGB:SRPGB:YOUDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
GB:ELIX and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
GB:ELIXElixirr International Plc496.00-355.87-41.77%
GB:CPICapita plc256.50-51.50-16.72%
GB:GTLYGateley (Holdings)71.50-36.27-33.66%
GB:DATAGlobalData plc64.40-39.69-38.13%
GB:SRPSerco Group plc288.2041.0916.63%
GB:YOUYougov plc272.2021.218.45%

Elixirr International Plc Corporate Events

Business Operations and StrategyDelistings and Listing ChangesRegulatory Filings and Compliance

Elixirr Clarifies Line‑Up of Joint Corporate Brokers

Positive
Sep 22, 2026

Elixirr International plc is an award‑winning global consulting firm that positions itself as a challenger to traditional large corporate consultancies. Founded in 2009, it serves clients across diverse industries and geographies and has expand...

Business Operations and StrategyExecutive/Board ChangesFinancial Disclosures

Elixirr Delivers Record Half-Year as AI Work and Major Client Growth Accelerate

Positive
Sep 21, 2026

Elixirr International reported record interim results for the six months to 30 June 2026, with revenue rising 25% to £89.0m and adjusted EBITDA up 29% to £27.6m, lifting the margin to 31%. Adjusted profit before tax increased 25% to £2...

Business Operations and StrategyFinancial Disclosures

Elixirr Sets September Dates for H1 2026 Results and Investor Presentation

Positive
Sep 15, 2026

Elixirr International plc will publish its half-year results for the period ended 30 June 2026 on 21 September and follow up with a live investor presentation on 23 September via the Investor Meet Company platform. The event, open to existing and pot...

Business Operations and StrategyExecutive/Board ChangesFinancial Disclosures

Elixirr Posts Record H1 Results and Bolsters U.S. Push with New Broker

Positive
Aug 3, 2026

Elixirr International, a global challenger consulting firm focused on commercial transformation, technology and AI services, reported strong growth for the first half of 2026, highlighting its expanding role in AI-enabled consulting. The London-liste...

Business Operations and StrategyExecutive/Board ChangesRegulatory Filings and Compliance

Elixirr CFO Exercises Share Options Without Diluting Equity

Positive
Jul 10, 2026

Elixirr International Plc reported that Chief Financial Officer and Company Secretary Nicholas Willott has exercised options over 100,000 ordinary shares at an exercise price of 43.365p per share, with the shares sourced from the company’s Empl...

Business Operations and StrategyShareholder Meetings

Elixirr Wins Strong Shareholder Backing as All AGM Resolutions Pass

Positive
Jun 30, 2026

Elixirr International plc, the award-winning challenger consultancy, operates globally across diverse sectors and focuses on collaborative, outcome-driven advisory services that differentiate it from larger incumbents. Since its 2009 founding, the fi...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 28, 2026